Division of Neurosurgery, Department of Neurological Sciences, Università degli Studi di Napoli Federico II, Naples, Italy.
Neurosurgery Department, P.O. Santa Maria delle Grazie Hospital, Neurosurgery Unit, ASL Napoli 2 Nord, Via Domiziana 1, Naples, 80078, Italy.
Neurosurg Rev. 2024 Oct 22;47(1):811. doi: 10.1007/s10143-024-03056-x.
Pregnancy and lactation-associated osteoporosis is a rare form of osteoporosis occurring during late pregnancy and early lactation, featuring fragility fractures, primarily involving the vertebral bodies and leading to back pain. Its management involves osteoporosis treatment, complicated by potential drug-related dangerous effects on the fetus. Nevertheless, many controversies remain regarding diagnosis, prognosis, and treatment options. Herein, we propose a multicentric case series to provide a comprehensive neurosurgical, gynecological, and endocrinological perspective on the management of pregnancy and lactation-associated osteoporotic vertebral fractures. A multicenter retrospective study was conducted at the Neurosurgical Department of Università degli Studi di Napoli Federico II, the Neurosurgical Unit of Hopitaux Universitaires de Genève, and the Spine and Spinal Cord Surgery Unit of the University Hospital of Udine, collecting data from January 2014 to December 2022. The study has been approved by the ethical committee of each hospital. N = 11 patients with an overall number of 31 fractures were eligible, with a mean age of 36. N = 5 (16%) fractures in 4 patients (36%) developed during pregnancy, and N = 26 (84%) fractures in 7 (64%) patients occurred during lactation. The mean number of fractures per patient was 2,81. In 10 (90%) patients, fractures occurred at the first pregnancy, and 5 (45%) patients had uneventful subsequent pregnancies. The mean clinical signs and symptoms were back pain (92%), followed by loss of height (75%) and kyphosis (4 patients, 35%). One (9,09%) patient underwent in vitro fertilization (IVF), and one patient (9,09%) was receiving hormonal therapy (ethinylestradiol/drosiprenone). 10 out of 11 (90%) patients were treated conservatively, and 6 of them (60%) were managed with an orthosis. One (9,1%) patient underwent surgery for 5-level kyphoplasty. The mean average reduction of pain after one year of follow-up was 6,7 on the visual analogue scale (p-value 0,04). Pregnancy-related osteoporotic vertebral fractures are an emerging issue in developing countries, for which a conservative strategy ensures the best outcomes. The main goal is to improve bone mineral density through calcium and vitamin D supplementation and bone-active drugs as bisphosphonates or teriparatide. Surgery is warranted only in cases of a risk of severe deterioration of neurological functions.
妊娠和哺乳期相关骨质疏松症是一种罕见的骨质疏松症形式,发生在妊娠晚期和哺乳期早期,表现为脆性骨折,主要累及椎体,并导致背痛。其管理包括骨质疏松症治疗,但可能会对胎儿产生潜在的药物相关危险影响。然而,在诊断、预后和治疗选择方面仍存在许多争议。在此,我们提出了一项多中心病例系列研究,从神经外科、妇科和内分泌学的角度全面探讨妊娠和哺乳期相关骨质疏松性椎体骨折的治疗。
这项多中心回顾性研究在那不勒斯费德里克二世大学神经外科系、日内瓦大学附属医院神经外科和乌迪内大学医院脊柱和脊髓外科单位进行,收集了 2014 年 1 月至 2022 年 12 月的数据。该研究已获得每家医院伦理委员会的批准。
共有 11 名患者(31 处骨折)符合条件,平均年龄为 36 岁。4 名患者(36%)的 5 处(16%)骨折发生在妊娠期间,7 名患者(64%)的 26 处(84%)骨折发生在哺乳期。每位患者的平均骨折数为 2.81 处。在 10 名(90%)患者中,骨折发生在第一次妊娠时,5 名(45%)患者随后的妊娠均无异常。平均临床症状为背痛(92%),其次是身高下降(75%)和后凸畸形(4 名患者,35%)。1 名(9.09%)患者接受了体外受精(IVF),1 名(9.09%)患者正在接受激素治疗(炔雌醇/屈螺酮)。11 名患者中有 10 名(90%)接受了保守治疗,其中 6 名(60%)患者使用矫形器治疗。1 名(9.09%)患者接受了 5 级椎体后凸成形术治疗。在 1 年的随访后,疼痛平均缓解 6.7 分(p 值为 0.04)。
妊娠相关骨质疏松性椎体骨折是发展中国家的一个新兴问题,保守策略可确保最佳疗效。主要目标是通过钙和维生素 D 补充以及双膦酸盐或特立帕肽等骨活性药物来提高骨密度。只有在存在严重神经功能恶化风险的情况下才需要手术。